Enliven Therapeutics Inc.
22.67
2.21 (10.80%)
At close: Jan 15, 2025, 1:32 PM

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Cash & Equivalents 100.14M 75.54M 110.02M 130.37M 4.94M 7.38M 9.67M
Short-Term Investments 153.01M n/a 41.97M 40.52M 23.97M n/a n/a
Long-Term Investments n/a 54.00K 175.00K 88.00K 88.00K n/a n/a
Other Long-Term Assets 4.65M 3.98M 1.53M -88.00K 2.14M n/a n/a
Receivables n/a n/a n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a n/a n/a
Other Current Assets 13.00M 2.22M 646.00K 222.00K 1.72M 323.00K 552.00K
Total Current Assets 266.15M 77.75M 110.67M 130.59M 30.62M 7.71M 10.22M
Property-Plant & Equipment 1.06M 1.52M 954.00K 416.00K 442.00K n/a n/a
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 5.72M 5.54M 2.66M 416.00K 2.67M n/a n/a
Total Assets 271.87M 83.30M 113.33M 131.00M 33.30M 7.71M 10.22M
Account Payables 532.00K 3.44M 2.52M 808.00K 1.66M 908.00K 431.00K
Deferred Revenue n/a 5.51M 2.70M 429.00K n/a n/a n/a
Short-Term Debt 335.00K 323.00K 159.00K 105.00K n/a n/a n/a
Other Current Liabilities 25.03M 5.95M 3.07M 565.00K 2.54M 924.00K 395.00K
Total Current Liabilities 25.89M 9.71M 5.75M 1.48M 4.20M 1.83M 826.00K
Long-Term Debt n/a n/a n/a n/a n/a n/a 660.00K
Other Long-Term Liabilities 67.00K 150.41M 150.46M 149.83M 184.00K 32.19M n/a
Total Long-Term Liabilities 67.00K 150.41M 150.46M 149.83M 184.00K 32.19M 660.00K
Total Liabilities 25.96M 160.12M 156.22M 151.31M 4.38M 1.83M 1.49M
Total Debt 335.00K 323.00K 159.00K 105.00K n/a n/a 660.00K
Common Stock 41.00K 1K 1K 1K 4.00K 4.00K 4.00K
Retained Earnings -154.45M -82.86M -45.20M -20.46M -54.75M -31.29M -19.95M
Comprehensive Income 141.00K -149.75K -16.00K 4.00K 32.00K n/a n/a
Shareholders Equity 245.91M -76.83M -42.89M -20.30M -48.85M -26.32M -15.53M
Total Investments 153.01M 54.00K 42.14M 40.61M 24.06M n/a n/a